NCT06650566
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06650566
Title Study of LM-299 in Subjects Advanced Malignant Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors LaNova Medicines Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
One Clinical Research NOT_YET_RECRUITING Perth Western Australia Australia Details
the first affiliated hospital of Xinxiang medical University NOT_YET_RECRUITING Xinxiang Henan China Details
Liaocheng people's hospital NOT_YET_RECRUITING Liaocheng Shandong China Details
Zibo municipal hospital NOT_YET_RECRUITING Zibo Shandong China Details
Shanghai Dongfang Hospital (Tongji University Affiliated Dongfang Hospital) NOT_YET_RECRUITING Shanghai Shanghai Municipality China Details
Shanghai GoBroad Cancer Hospital China Pharmaceutical University RECRUITING Shanghai Shanghai Municipality China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field